| Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment SK Malladi, R Singh, S Pandey, S Gayathri, K Kanjo, S Ahmed, MS Khan, ... Journal of Biological Chemistry 296, 2021 | 53 | 2021 |
| Immunogenicity and protective efficacy of a highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative SK Malladi, UR Patel, RS Rajmani, R Singh, S Pandey, S Kumar, ... ACS Infectious Diseases 7 (8), 2546-2564, 2021 | 35 | 2021 |
| Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity S Kumar, R Delipan, D Chakraborty, K Kanjo, R Singh, N Singh, ... Journal of Virology 97 (11), e00922-23, 2023 | 12 | 2023 |
| Efficacy of ultraviolet-C devices for the disinfection of personal protective equipment fabrics and N95 respirators KM Chandran, PC Ramamurthy, K Kanjo, R Narayan, SR Menon Journal of Research of the National Institute of Standards and Technology 126, 2021 | 7 | 2021 |
| Truncated, strong inducible promoter Pmcl1 from Metarhizium anisopliae K Kanjo, SI Surin, T Gupta, M Dhanasingh, B Singh, GK Saini 3 Biotech 9, 1-6, 2019 | 3 | 2019 |
| Design, Biophysical Characterization, and Serum Epitope Mapping of SARS-CoV-2 RBD Vaccine Immunogens K Kanjo | | 2025 |
| Vaccine Research and Development in India for COVID-19 and Influenza K Kanjo, G Chakshusmathi, R Varadarajan Biotechnology in India-Reworking A Strategy, 147-173, 2024 | | 2024 |
| Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants I Das Jana, K Kanjo, S Roy, M Bhasin, S Bhattacharya, I Banerjee, S Jana, ... bioRxiv, 2024.07. 08.602485, 2024 | | 2024 |
| Biophysical Correlates of Enhanced Immunogenicity of a Stabilized Variant of the Receptor Binding Domain of SARS-CoV-2 K Kanjo, G Chattopadhyay, SK Malladi, R Singh, S Jayatheertha, ... The Journal of Physical Chemistry B 127 (8), 1704-1714, 2023 | | 2023 |
| Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment immunogen SK Malladi, R Singh, S Pandey, S Gayathri, K Kanjo, S Ahmed, MS Khan, ... bioRxiv, 2020.08. 15.252437, 2020 | | 2020 |
| Immunogenicity and protective efficacy of a highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative MSK Upadhyaya, K Kanjo, M Bhat, S Mani, S Bhattacharyya, S Siddiqui, ... | | |
